Formerly known as ACTAVIS PHARMA COMPANY
Shortage reports
Actual shortage:
280 (9%)
Anticipated shortage:
6 (0%)
Avoided shortage:
10 (0%)
Resolved:
2981 (91%)
3277
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
484 (13%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-12-08 | 2022-12-15 | 177532 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2020-12-17 | 2021-06-03 | 130282 |
| TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195195 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273243 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2020-09-11 | 2022-12-15 | 124110 |
| TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 127995 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-10-05 | 2023-10-19 | 206386 |
| TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2021-03-25 | 2021-06-03 | 136350 |
| TREANDA | 25MG | POWDER FOR SOLUTION | Resolved | 2024-11-08 | 2025-01-17 | 242338 |
| TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2021-01-28 | 2021-02-11 | 132644 |
| TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2024-11-28 | 2025-05-02 | 244075 |
| TRISENOX | 10MG | SOLUTION | Actual shortage | 2020-05-14 | 2022-06-03 | 115216 |
| TRISENOX | 1MG | SOLUTION | Resolved | 2017-07-14 | 2018-07-30 | 15753 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2024-12-10 | 2025-04-24 | 245304 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-03-12 | 2020-08-27 | 108601 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2020-11-06 | 2021-01-07 | 128028 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-10 | 92198 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-01-27 | 98185 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-28 | 2020-06-25 | 99955 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-02-21 | 2020-04-09 | 106925 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |